Compare Humana Inc (HUM) vs 3M Company (MMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs 3M Company — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while 3M Company trades at $159.96 (market cap $84.36B). The key difference: 3M Company is the larger of the two by market cap, and 3M Company pays the higher dividend (1.91%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and 3M Company for 169 Days on average.
| HUM | MMM | |
|---|---|---|
Market Cap | $46.49B | $84.36B |
Volume | 2,567,704 | 2,325,301 |
Sector | Health | Industrials |
52-Week High | $431.03 | $183.79 |
52-Week Low | $163.67 | $141.10 |
Typical Hold Time | 51 Days | 169 Days |
Enterprise Value | $53.84B | $93.58B |
Dividend Yield | 0.91% | 1.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
3M (MMM) trades at $163.57, up 0.89% on the day, with a mixed technical picture showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with $2.40 EPS versus $2.25 expected, and raised full-year guidance. Revenue for 2025 was $24.95 billion with a net income margin of 11.9%, though profitability has moderated from prior years. Analysts maintain a consensus price target of $191.00, implying significant upside, with 48% recommending Buy.
The outlook for 3M is cautiously optimistic, driven by operational improvements and growth in industrial and electronics segments, but risks include high debt levels, weak consumer demand, and ongoing litigation costs. The stock's valuation at a P/E of 29.06 appears elevated relative to historical norms, requiring sustained earnings growth to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
